For patients treated with anti-IL-4, SNOT-22 subdomains were analyzed according to Khan’s five-domain model (Table 3): rhinologic symptoms (Domain 1), extranasal rhinologic symptoms (Domain 2), ear/facial symptoms (Domain 3), sleep dysfunction (Domain 4), and psychological dysfunction (Domain 5). The gene discussed is IL4; the disease is Sleep disturbance.